Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsHerantis Pharmas clinical study with CDNF in Parkinsons disease authorized in Sweden
(WorldNews Finland)

 
 

23 march 2017 12:41:23

 
Herantis Pharmas clinical study with CDNF in Parkinsons disease authorized in Sweden
(WorldNews Finland)
 


Herantis Pharma`s clinical study with CDNF in Parkinson`s disease authorized in Sweden Herantis Pharma Plc Company release 23 March 2017 at 12:30 pm The Medicines Agency of Sweden, MPA, has authorized Herantis Pharma Plc`s (`Herantis`) first-in-human clinical study of the company`s investigational product CDNF for the treatment of Parkinson`s disease. Patient recruitment in the randomized, placebo-controlled Phase 1-2 clinical study is planned to begin in Sweden in the first half of 2017. `CDNF is a novel neurotrophic and neuroprotective factor, which affects several mechanisms relevant to Parkinson`s disease`, explains Sigrid Booms, Herantis` Director, Clinical Development. `Based on...


 
4 viewsCategory: General > Europe > Finland
 
Esko Aho to examine positive structural change in Varsinais-Suomi region
(WorldNews Finland)
ORGANIZATION OF THE BOARD OF ASPOCOMP GROUP PLC
(WorldNews Finland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten